Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Charmacy Pharmaceutical CoHKSE:02289 76 Days Payable is 38.81 as of Dec. 2025, which is 31% below its 10-year median of 56.28. GuruFocus rates HKSE:02289 with a GF Score™ of 76/100 and a GF Value™ of HK$8.38 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Charmacy Pharmaceutical Co ranks worse than 85.47% on this metric.
The historical rank and industry rank for Charmacy Pharmaceutical Co's Days Payable or its related term are showing as below:
HKSE:02289'
s Days Payable Range Over the Past 10 Years
Min: 37.71 Med: 56.28 Max: 141.98
Current: 37.71
During the past 12 years, Charmacy Pharmaceutical Co's highest Days Payable was 141.98. The lowest was 37.71. And the median was 56.28.
HKSE:02289's Days Payable is ranked worse than 85.47% of 117
companies
in the Medical Distribution industry
Industry Median: 76.55
vs HKSE:02289: 37.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02289 vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charmacy Pharmaceutical Co Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Charmacy Pharmaceutical Co's Days Payable falls into.
Charmacy Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charmacy Pharmaceutical Co (HKSE:02289) has a Days Payable of 38.81 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Charmacy Pharmaceutical Co and its competitors. This is 31% below median its historical median of 56.28. Over the past decade, Charmacy Pharmaceutical Co's Days Payable has ranged from 37.71 to 141.98. According to the industry distribution chart, Charmacy Pharmaceutical Co ranks #100 out of 117 companies in the Medical Distribution industry, placing it in the top 85.5%.
Is Charmacy Pharmaceutical Co's Days Payable too high?
Charmacy Pharmaceutical Co's current Days Payable of 38.81 is 31% below median its 10-year median of 56.28. Over the past 10 years, this metric has ranged from a low of 37.71 to a high of 141.98. The Medical Distribution industry median Days Payable is 76.55. Charmacy Pharmaceutical Co's value of 38.81 is 49.3% below this industry median. Based on the distribution chart, Charmacy Pharmaceutical Co ranks #100 out of 117 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Charmacy Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Charmacy Pharmaceutical Co's Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Charmacy Pharmaceutical Co ranks #100 out of 117 companies for Days Payable. This places Charmacy Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 76.55. Charmacy Pharmaceutical Co's value of 38.81 is 49.3% below this benchmark. Historically, Charmacy Pharmaceutical Co's own Days Payable has ranged from 37.71 to 141.98 over the past decade. While the company's 10-year median is 56.28 vs. the industry median of 76.55, Charmacy Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 76.55, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Charmacy Pharmaceutical Co's current Days Payable of 38.81 is 49.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Charmacy Pharmaceutical Co and its competitors. For the Medical Distribution industry, the median Days Payable is 76.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charmacy Pharmaceutical Co's current Days Payable is 38.81, which is 31% below median its own 10-year median of 56.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charmacy Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co (HKSE:02289) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.38, compared to a current price of HK$5.50 — trading 34.4% below its estimated fair value. The current Days Payable is 38.81, which is 31% below median its 10-year median of 56.28 and 49.3% below the Medical Distribution industry median of 76.55. Charmacy Pharmaceutical Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Charmacy Pharmaceutical Co (HKSE:02289), the current Days Payable is 38.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charmacy Pharmaceutical Co (HKSE:02289) Overvalued in 2026?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co stock appears to be undervalued.
The current stock price of HK$5.50 is trading 34.4% below its estimated GF Value™ of HK$8.38.
GuruFocus considers Charmacy Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for HKSE:02289:
Days Payable: 38.81 (31% below median its 10-year median of 56.28)
GF Value™: HK$8.38 vs. price of HK$5.50 (34.4% below fair value)
Industry Position: 49.3% below the Medical Distribution median (#100 of 117)
No single metric tells the full story. See the HKSE:02289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charmacy Pharmaceutical Co Ltd operates within the pharmaceutical distribution industry, with a primary focus on the distribution of pharmaceutical products. The principal business activities encompass the wholesale of pharmaceuticals and related services, along with road transportation and cargo warehousing. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
76GF Score
Get the complete analysis for HKSE:02289
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02289 has been successfully added to your 
